Silastic Stent Study
Pituitary Tumour
About this trial
This is an interventional supportive care trial for Pituitary Tumour focused on measuring Silastic Stenting, Trans-nasal Endoscopic Surgery, Post-operative Intra-nasal Re-mucosalization
Eligibility Criteria
Inclusion Criteria:
- patients undergoing trans-sphenoidal endoscopic pituitary surgery at their first post-operative appointment
Exclusion Criteria:
- patients with inflammatory sinus conditions
- patients having undergone extensive skull base reconstructions
- patients having received previous radiotherapy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Silastic Stent
No Stent
At the time of surgery, if the patient is identified in the "silastic stent" arm, dressing of the septal donor site with silastic stents will be performed after reconstruction has been achieved and the surgeon feels that the surgery proceeded routinely.
At the time of surgery, if the patient is identified in the "no silastic stent" arm, dressing of the septal donor site without the stent will be performed after reconstruction has been achieved and the surgeon feels that the surgery proceeded routinely - this is currently the standard of care.